These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11350066)

  • 1. A distinct subnuclear localization of mammalian DNA topoisomerase IIbeta in yeast.
    Sakaguchi A; Akashi T; Kikuchi A
    Biochem Biophys Res Commun; 2001 May; 283(4):876-82. PubMed ID: 11350066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain.
    Adachi N; Miyaike M; Kato S; Kanamaru R; Koyama H; Kikuchi A
    Nucleic Acids Res; 1997 Aug; 25(15):3135-42. PubMed ID: 9224616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.
    Mirski SE; Gerlach JH; Cole SP
    Exp Cell Res; 1999 Sep; 251(2):329-39. PubMed ID: 10471318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a single nuclear localization signal in the C-terminal domain of an Aspergillus DNA topoisomerase II.
    Kim KH; Kanbe T; Akashi T; Mizuguchi I; Kikuchi A
    Mol Genet Genomics; 2002 Nov; 268(3):287-97. PubMed ID: 12436251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear distribution of human DNA topoisomerase IIbeta: a nuclear targeting signal resides in the 116-residue C-terminal tail.
    Cowell IG; Willmore E; Chalton D; Marsh KL; Jazrawi E; Fisher LM; Austin CA
    Exp Cell Res; 1998 Sep; 243(2):232-40. PubMed ID: 9743583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines.
    Mo YY; Beck WT
    Oncol Res; 1997; 9(4):193-204. PubMed ID: 9268990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
    Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
    Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.
    Wasserman RA; Wang JC
    Cancer Res; 1994 Apr; 54(7):1795-800. PubMed ID: 8137294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.
    Gromova I; Biersack H; Jensen S; Nielsen OF; Westergaard O; Andersen AH
    Biochemistry; 1998 Nov; 37(47):16645-52. PubMed ID: 9843432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
    Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
    Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of catalytic activity and nucleolar localization of rat DNA topoisomerase IIα through its C-terminal domain.
    Yasuda K; Kato Y; Ikeda S; Kawano S
    Genes Genet Syst; 2021 Mar; 95(6):291-302. PubMed ID: 33551432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistance.
    Leontiou C; Lakey JH; Lightowlers R; Turnbull RM; Austin CA
    Mol Pharmacol; 2006 Jan; 69(1):130-9. PubMed ID: 16239602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
    McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
    Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both alpha and beta isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis.
    Null AP; Hudson J; Gorbsky GJ
    Cell Growth Differ; 2002 Jul; 13(7):325-33. PubMed ID: 12133901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linker insertion mutagenesis of Drosophila topoisomerase II. Probing the structure of eukaryotic topoisomerase II.
    Lee MP; Hsieh TS
    J Mol Biol; 1994 Jan; 235(2):436-47. PubMed ID: 8289273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic DNA topoisomerase II beta.
    Austin CA; Marsh KL
    Bioessays; 1998 Mar; 20(3):215-26. PubMed ID: 9631649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposide.
    Leontiou C; Lakey JH; Austin CA
    Mol Pharmacol; 2004 Sep; 66(3):430-9. PubMed ID: 15322234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
    Sakaguchi A; Kikuchi A
    J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.